Vice President of Investor Relations, Corporate Communications and Public Relations
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Eric has over 25 years of Wall Street experience in institutional equities servicing investors worldwide as a specialist in Life Sciences. As an investor relations and communication professional, Eric uses his knowledge and relationships to execute a comprehensive Communications and IR strategy, message, position with purpose, and attract investors. Specialties: Healthcare, Biotechnology, Life Sciences, Investment Banking, Institutional Sales, Technical Analysis, Options, Terms Sheets, Commercial Lending, Hedge Funds, Mutual Funds, Business Models, Business Plans, Strategic Partnerships, Mergers & Acquisitions, Equities, Debt, Venture Capital, Alternative Investments, Corporate Development.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of Eric Laub at Jounce Therapeutics then you’ve come to the right place.
Wondering if it's eric@jouncetx.com, eric.laub@jouncetx.com, laub@jouncetx.com, or elaub@jouncetx.com? We have the answers for you.